Training - Education & Training Programme (ETP)
The safest use of drugs through contributing to appropriate education in pharmacovigilance
ETP Committee Chaired by Andrew Bate (ISoP Executive Committee member – 2012-2015)
Introduction and Aims
A primary objective of ISoP is to promote the safest use of drugs through contributing to appropriate education in pharmacovigilance (PV) and training activities worldwide. The ISoP Education and Training Programme Committee (ETP) set up in 2003, works to develop a continual robust educational programme, available internationally which includes a training programme (‘mid-year training’, courses and pre-conference courses during the Annual Meetings), and will include a PV curriculum. ETP will work on a landscape analysis of other educational societies and scientific organizations in related or similar fields to prioritize goals and reinforce collaboration with international societies and organizations including the WHO-UMC. The Executive Committee (EC) itself has a wide range of expertise that can be brought to bear in providing PV education, and indeed the entire society itself has a wide range of international PV expertise, naturally given our membership from 67 countries, many of whom are keen to share their expertise in contributing to PV education and training courses. ISoP therefore can provide education on almost any element of PV and will do all we can to support Pharmacovigilance training around the world.
The ETP is very keen to hear about opportunities for PV training where we might contribute, please do get in touch by emailing Sophie Spence at ISoP Administration.
We would wish to reiterate that we are a not-for-profit society, so unfortunately we cannot routinely fund such educational activities. In the past, ISoP has a rule to grant bursaries on a case by case basis to enable attendance of young scientists to ISoP Annual meetings and training but this scheme is currently under discussion within the Executive Committee (EC) and how we can best support such young scientists.
The ETP programme team is conducting its business by phone, video conferences or e-mail, and twice a year, the ETP committee presents its activities and reports to the Executive Committee at its regular meetings.
Please contact us on email@example.com
Mid-year Training Courses
Each year for the following year, the outline plan of ISoP mid-year training course(s) (theme and location) is agreed by the Executive Committee (EC), who invite the Education Training Programme team (ETP) to co-ordinate its organisation with help and partnership of a local organiser.
Training guidelines are available here and to learn more about our latest course(s) click here
Courses are run in parallel, usually as two-day of training courses with the possibility to have course in parallel for beginners (basic concepts) and an advanced course.
Time: mid-year (usually spring, but other months can be considered).
The training courses will be attended by ISoP members and by non-ISoP members. Specific countries may be targeted (according to the venue). Decisions on where to hold the mid-year training courses are decided by the EC on a case by case basis. ISoP support will be considered, but ISoP cannot fund training activities.
No honorarium will be accepted by EC or ISoP members who speak on a mid-year training.
Training at Annual Meetings
We are keen to conduct training courses in addition to that at the annual and mid year meetings.
Training tends to take the following basic patterns:
Basic pharmacovigilance: 1 to 3-day courses
Advanced pharmacovigilance: e.g. risk management, benefit-to-harm assessment, decision making: 1 or 2 day courses Adhoc: for example on clinical trial safety, pharmacogenetics, immunopharmacovigilance, ecopharmacovigilance. That said, we look to tailor education for any specific audience and are also keen to collaborate with other societies in the provision of educational material.
Regarding additional requests for training courses from all countries outside the regular mid-year training courses, decisions must be taken by the EC before informing the requestor.
General request for offers to conduct PV training courses with the collaboration of ISoP, and if ISoP members or ISoP chapters feel a strong need for PV training in their country, please contact us at firstname.lastname@example.org
An ETP meeting was held in October 2008 during the Annual Meeting in Buenos Aires where a detailed proposal of practical training was presented. Within this concept, sections on materials or tools will be provided to potential participants in a PV course based on the curriculum and sections on tasks to be carried out by the course participants. The final curriculum with 15 or so modules is intended to be appropriate for ‘worldwide use’ (and not only for use in Europe) and in different settings (students at university, post-graduate courses, master courses, training courses etc.).
The WHO-ISoP Pharmacovigilance Curriculum is now public!
ISoP is very pleased to inform you that the Pharmacovigilance Curriculum, developed by experts from ISoP, WHO and institutions dedicated to pharmacovigilance, is available electronically on the Springer website. If you are member of ISoP, you may also have access to the document via the ISoP website at the members section. The curriculum contains a theoretical part in a comprehensive modular form, practical tasks and some key literature references. The PV curriculum can be used by everyone who needs to plan and conduct training courses in pharmacovigilance. The printed version is in the conference volume of Drug Safety at the occasion of the 14th ISoP Annual Meeting in Tianjin in October 2014. The authors would be interested in receiving your comments by contacting ISoP at email@example.com or the corresponding author directly. The authors would like to know about any experience you made when using the curriculum in practice.
ISoP Joint Sessions
ISoP is much interested in co-organizing joint symposia with other scientific societies aimed at improving the culture of pharmacovigilance all over the world.
Scientific societies interested in such co-operations can contact the ISoP Secretariat: firstname.lastname@example.org
Please click here for information about our ISoP-ENTIS joint training (2-3 June 2016, Berlin-Germany)
ISoP joint session with Greek scientific societies in Athens, Greece – 14 November 2014:
The 1st International congress “From Drug Discovery to Drug Delivery” took place in Athens, Greece from 13 to 15 November 2014. The congress was organized by The Hellenic Pharmaceutical Society, The Hellenic Society of Medicinal Chemistry and the International Liposome Society, and it was chaired by Prof. Gregory Gregoriadis (University of London, UK), Prof. Costas Demetzos (University of Athens, Greece) and Prof. Anna Tsantili-Kakoulidou (University of Athens, Greece). ISoP was requested to participate in the organization of a joint session during the congress dedicated to hot topics in pharmacovigilance and entitled “Drug safety monitoring and beyond”. The session was attended by about 70 participants from several countries, mostly European. During the session, Marco Tuccori (University Hospital of Pisa, Italy) provided a presentation entitled “General overview on the safety of antidiabetics drugs”. The second presentation by Nicole Baker (Quintiles, Ireland) was about “Post Authorization Safety Studies and Post Authorization Efficacy Studies in Line with the 2012 European pharmacovigilance legislation”. The session was closed by Giannis Papadopoulos (National and Kapodistrian University of Athens, Greece), with a presentation entitled “The adverse drug reactions of biotechnological medicines for rheumatoid arthritis and the role of healthcare professionals”. The session had a participatory and lively debate, and the joint session was a success.